Meghmani Organics Limited (NSE: MOL, BSE: 543331) reported a strong financial recovery for the fiscal year ended March 31, 2025 (FY25), reversing its previous year’s losses on the back of robust volume growth, margin expansion, and strategic product mix realignment across its Crop Protection and Pigments businesses.
Standalone revenue from operations rose 30% year-on-year to ₹2,003.9 crore in FY25, up from ₹1,539.9 crore in FY24. The company recorded a net profit of ₹66.4 crore, a sharp turnaround from a loss of ₹56.6 crore in the prior year. EBITDA surged more than 18-fold from ₹9.5 crore in FY24 to ₹180.4 crore in FY25, resulting in an EBITDA margin expansion from 0.6% to 9.0%.
For the fourth quarter, Meghmani Organics posted revenue of ₹502.1 crore, up 26% YoY, while net profit rose to ₹34.0 crore compared to a minor loss of ₹0.4 crore in Q4 FY24. Q4 EBITDA jumped to ₹64.6 crore from ₹10.1 crore in the year-ago quarter, indicating healthy operational leverage.
This turnaround aligns with the broader resurgence seen across India’s agrochemical and pigment sectors in FY25, supported by normalised weather cycles, rural demand recovery, and China+1 sourcing dynamics benefiting domestic chemical manufacturers.
What Supported Growth in Crop Protection and Pigments?
Meghmani Organics’ strong FY25 performance was led by the Crop Protection segment, which generated ₹1,450.6 crore in revenue—accounting for roughly 72% of the total topline. Segment EBITDA surged 301% YoY to ₹177.2 crore, driven by improved product mix, higher utilisation, and scaling of core pesticide offerings.
Capacity utilisation in this segment reached 76%, with total production climbing 14% year-on-year to 41,892 metric tonnes. The company maintains over 40 pesticide brands and caters to more than 400 customers across India and 75+ countries globally, supported by a distribution network of 3,500+ dealers.
The Pigments division contributed ₹553.3 crore in revenue (28% of FY25 topline), up 20% YoY. Segment EBITDA recovered to ₹26.9 crore from a negative ₹6.6 crore in FY24. Production volume rose 11% YoY to 15,237 metric tonnes, though utilisation remained low at 46%, largely due to ongoing pricing pressure in the Titanium Dioxide (TiO2) category.
How Are Strategic Moves Shaping Future Earnings Potential?
Chairman and Managing Director Ankit Patel credited the strategic shift toward value-added products and enhanced field activities as key growth drivers in FY25. He confirmed that the Crop Nutrition segment achieved self-sufficiency during the year—a critical operational milestone.
For FY26, the company plans to expand its Crop Nutrition product portfolio with 2–3 new launches. Demonstrations showcasing the effectiveness of Meghmani Nano Urea across various crops continue to underpin brand awareness and on-ground traction.
In the TiO2 pigment space, Meghmani has built a diversified customer base spanning ceramics, rubber, plastic, paint, and textile sectors. However, the segment has been impacted by aggressive dumping from China, depressing realisation and utilisation.
To counteract this, the Directorate General of Trade Remedies (DGTR) has proposed an anti-dumping duty of $460–681 per metric tonne on Chinese TiO2 imports. This measure, if enacted, is expected to stabilise pricing for domestic producers and restore demand-driven plant utilisation. Meghmani Organics is also expanding its TiO2 exports into countries that have already enforced such tariffs, enabling better margins and competitive positioning.
How Has Meghmani Organics’ Stock Reacted?
On May 9, 2025, Meghmani Organics’ stock closed at ₹70.85 on the NSE, rising 2.99% for the day. The stock has rebounded 26.27% from its 52-week low of ₹56.11 but remains 38.90% below its 52-week high of ₹115.95. The current rally is reflective of improving sentiment post the earnings release.
Technical indicators suggest mixed momentum. The Relative Strength Index (RSI) stands at 55.36—implying neutral territory. The Moving Average Convergence Divergence (MACD) is negative at -0.244, pointing to mild bearishness, while the ADX is 18.95, reflecting weak trend strength. The price is currently testing the Supertrend resistance near ₹72.28.
From a trading perspective, a decisive close above ₹84.5 could trigger upward targets around ₹93 and ₹96. A protective stop-loss is advised at ₹71 for those holding near current levels.
What Does Institutional Sentiment Reveal?
Institutional flows reflect growing interest in the stock. Promoter holdings edged up to 49.41% in Q4 FY25, from 49.33% in Q3. Domestic Institutional Investors (DIIs) increased their stake from 0.32% to 0.53% during the same period. While Foreign Institutional Investors (FIIs) marginally trimmed their holdings from 1.90% to 1.81%, the number of FII participants rose from 42 to 45—indicating expanding foreign interest.
This trend suggests stabilising institutional confidence in the company’s financial trajectory. Analysts believe sustained profitability and anti-dumping enforcement in TiO2 could catalyse further FII inflows in FY26.
How Are Analysts Rating Meghmani Organics Now?
Early market reaction has been cautiously optimistic. Analysts highlight that the 30% YoY revenue growth and the swing from loss to ₹66.4 crore PAT validate management’s operational improvements. The turnaround has also re-established earnings visibility, especially in the Crop Protection vertical, which remains the margin leader.
While uncertainties persist in the Pigments business due to global oversupply and underutilised capacity, analysts view the anti-dumping duty proposal as a potential inflection point. Successful implementation could unlock significant upside in capacity usage and segment margins in the coming quarters.
Investment houses covering the stock generally suggest a ‘Hold’ rating for conservative portfolios, with ‘Buy’ consideration on a confirmed breakout above ₹84.5.
What’s the FY26 Outlook for Meghmani Organics?
For FY26, Meghmani Organics aims to scale both its Crop Nutrition and TiO2 export verticals while continuing to optimise its product mix in Crop Protection. With global buyers seeking supply-chain diversification from China, Indian chemical companies like Meghmani are poised to benefit from long-term shifts in sourcing patterns.
Strategically, the company’s 85% export-dependent revenue mix, along with its global distribution in 75+ countries, provides resilience against domestic demand volatility. Management is also banking on value-added innovations and farmer-focused engagement to solidify its position in the agri-input space.
In the near term, investor attention will remain on EBITDA stability, plant utilisation in Pigments, and policy decisions related to anti-dumping tariffs. Analysts expect further earnings momentum if the company delivers consistency across all segments.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.
